title: Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease.
authors: G
authors: G
authors: Triolo
authors: M
authors: M
authors: Vadalà
authors: A
authors: A
authors: Accardo-Palumbo
authors: A
authors: A
authors: Ferrante
authors: F
authors: F
authors: Ciccia
authors: E
authors: E
authors: Giardina
authors: P
authors: P
authors: Citarrella
authors: G
authors: G
authors: Lodato
authors: G
authors: G
authors: Licata
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D012008:Recurrence; D012173:Retinitis / Q000150:complications / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab